Skip to Main content Skip to Navigation
Journal articles

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Lesley-Ann Sutton 1 Emma Young 1 Panagiotis Baliakas 1 Anastasia Hadzidimitriou 2 Theodoros Moysiadis 2 Karla Plevova 3 Davide Rossi 4 Jana Kminkova 3 Evangelia Stalika 2 Lone Bredo Pedersen 5 Jitka Malcikova 3 Andreas Agathangelidis 6, 7 Zadie Davis 8 Larry Mansouri 1 Lydia Scarfò 6, 7 Myriam Boudjoghra 9, 10 Alba Navarro 11 Alice F. Muggen 12 Xiao-Jie Yan 13 Florence Nguyen-Khac 10, 9 Marta Larrayoz 14 Panagiotis Panagiotidis 15 Nicholas Chiorazzi 13 Carsten Utoft Niemann 5 Chrysoula Belessi 16 Elias Campo 11 Jonathan C. Strefford 14 Anton W. Langerak 12 David Oscier 8 Gianluca Gaidano 4 Sarka Pospisilova 3 Frederic Davi 10, 9 Paolo Ghia 6, 7 Kostas Stamatopoulos 17, 1, 2 Richard Rosenquist 1
Abstract : We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobu-lins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobu-lin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hypermutation status) and subset #4 (1%, indolent disease, mutated immunoglobulin genes). Interestingly, subsets harboring a high frequency of NOTCH1 mutations were found to carry few (if any) SF3B1 mutations. This starkly contrasts with subsets #2 and #3 where, despite their immunogenetic differences, SF3B1 mutations occurred in 45% and 46% of cases, respectively. In addition , mutations within TP53, whilst enriched in subset #1 (16%), were rare in subsets #2 and #8 (both 2%), despite all being clinically aggressive. All subsets were negative for MYD88 mutations, whereas BIRC3 mutations were infrequent. Collectively, this striking bias and skewed distribution of mutations and cytogenetic aberrations within specific chronic lymphocytic leukemia subsets implies that the mechanisms underlying clinical aggressiveness are not uniform, but rather support the existence of distinct genetic pathways of clonal evolution governed by a particular stereotyped B-cell receptor selecting a certain molecular lesion(s).
Complete list of metadata

Cited literature [27 references]  Display  Hide  Download
Contributor : Gestionnaire Hal-Upmc Connect in order to contact the contributor
Submitted on : Monday, October 3, 2016 - 11:45:08 AM
Last modification on : Tuesday, July 13, 2021 - 1:58:03 PM
Long-term archiving on: : Friday, February 3, 2017 - 2:12:26 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License




Lesley-Ann Sutton, Emma Young, Panagiotis Baliakas, Anastasia Hadzidimitriou, Theodoros Moysiadis, et al.. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors . Haematologica, Ferrata Storti Foundation, 2016, 101 (8), pp.959 - 967. ⟨10.3324/haematol.2016.141812⟩. ⟨hal-01375537⟩



Record views


Files downloads